` PRPH (Prophase Labs Inc) vs S&P 500 Comparison - Alpha Spread

PRPH
vs
S&P 500

Over the past 12 months, PRPH has underperformed S&P 500, delivering a return of -95% compared to the S&P 500's +15% growth.

Stocks Performance
PRPH vs S&P 500

Loading
PRPH
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
PRPH vs S&P 500

Loading
PRPH
S&P 500
Difference
www.alphaspread.com

Performance By Year
PRPH vs S&P 500

Loading
PRPH
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Prophase Labs Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Prophase Labs Inc
Glance View

Market Cap
1.2m USD
Industry
Pharmaceuticals

ProPhase Labs, Inc. is a medical science and technology company. The company is headquartered in New York City, New York and currently employs 129 full-time employees. The firm operates through two segments: diagnostic services and consumer products. The diagnostic services segment provides COVID-19 diagnostic information services to a range of customers in the United States, including health plans, third-party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter (OTC) consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services. The firm is also engaged in the development and marketing of dietary supplements under the TK Supplements brand. The Company’s TK Supplements product line includes Legendz XL, a male sexual enhancement and Triple Edge XL, an energy and stamina booster.

PRPH Intrinsic Value
2.2012 USD
Undervaluation 90%
Intrinsic Value
Price
Back to Top